Clinical Trial Update: Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing intravitreal bevacizumab with intravitreal triamcinolone for Branch Retinal Vein Occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Branch Retinal Vein Occlusion | Phase 2 | Status: UNKNOWN